May. 02, 2019News & OpinionsHeadlines
US drugmaker Merck & Co. has begun a restructuring program of its manufacturing and supply network, as well as reducing its global real estate footprint.
May. 01, 2019News & OpinionsHeadlines
Swiss flavors, fragrances and active cosmetic ingredients manufacturer Givaudan has agreed to buy the cosmetics business of Germany’s AMSilk. The acquisition fits with Givaudan’s aim – part of its 2020 strategy – to ...
French technology provider Axens has won contracts in China and India to supply several of its proprietary process units.
Wacker Biotech, a subsidiary of the Munich- based German chemical producer, has signed a license agreement with US biopharmaceutical company PhaseBio Pharmaceuticals to produce and antibody fragment known as PB2452.
Apr. 30, 2019News & OpinionsHeadlines
The business unit Precious Metals Chemistry of Umicore is expanding its cross-coupling catalyst portfolio with Hazari’s palladium based precatalysts, a technology licensed from Yale University.
Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications.
Two months earlier than expected, the US Food and Drug Administration (FDA) has greenlighted the use of Merck & Co’s multi-indication cancer treatment Keytruda in combination with Pfizer’s Inlyta as a treatment for ...
As the end of April and international Labor Day May 1 approached, 240 striking union members at a Dow specialty chemicals production site in Deer Park, Texas remained locked out without pay or benefits.
The latest information directly via newsletter.